With over 200,000 ultrasound systems delivered worldwide, ALOKA, which has been a leading innovator in ultrasound for half a century, continues to enhance the ProSound family of high performance products. At MEDICA this year, the company is introducing its latest development: the ProSound a7. To deliver high definition images on a LCD monitor, ease of use and a compact form design, the ProSound…
Today, ultrasound is present in most specialised medical fields, and even used in small practices. However, in terms of quality, when using ultrasonic equipment in the low price segment, users often had to compromise in terms of quality.
Toshiba's new Artida Ultrasound system is the world's first ultrasound system that can track and display myocardial wall motion three-dimensionally.
At Medica, this year, SonoSite is presenting innovations - M-Turbo and the S-series - which present numerous technical improvements and deliver a breakthrough image quality, the company reports.
A new research collaboration to study the potential of microbubbles and ultrasound to treat ischemic strokes has been established between ImaRx Therapeutics, a biopharmaceutal company in Tucson, Arizona, and the Philips' Medical Systems division in Andover, Massachusetts.
A presentation for the 31st tri-national DEGUM, ÖGUM, and SGUM conference in Leipzig, Germany, by Axel Feldkamp MD (below), Chairman of the DEGUM paediatrics division, and Director of the paediatrics department at Duisburg Hospital.
The Acuson P10 - barely bigger than your BlackBerry and weighing just 500 grams.
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
Myocardial perfusion is considered a sensitive marker for the diagnosis of coronary heart disease. Currently, the most frequently used imaging procedure to gain information about the status of myocardial perfusion is a nuclear stress test. This situation is about to change as Imagify (Perflubutane Polymer Microspheres), developed by Acusphere, Inc., could become the first injectable…
Radiologist Dr Myriam Hunink is a Professor in the Epidemiology and Biostatistics and the Radiology Departments at the Erasmus MC in the university medical centre, Rotterdam, the Netherlands, where she is also project leader for several research projects focused on radiology and epidemiology.
A specialist in radiology and neuroradiology, Dr Birgit Ertl-Wagner is senior physician for teleradiology at the Institute for Clinical Radiology, in Grosshadern University Hospital, Munich. She studied medicine at Ludwig-Maximilians University, in Munich, and gained her doctorate for her thesis on neuroradiology at the Max-Planck-Institut Martinsried. She has worked in her profession in the USA,…
Magnetic Field Imaging (MFI) provides cardiologists with an additional tool to detect arrythmia and irregular cardiac blood flow and thus contributes to a more precise diagnosis. While an ECG acquires electric signals produced by the activity of the cardiac muscle, MFI measures the electrophysical function of the heart by determining the magnetic field during a heartbeat.
Imaging water molecules in the brain correlates structural and functional deficits
ulrich medical, established 25 years ago, is an independent medium-size medical technology firm with worldwide sales. Among its products are contrast agent injectors for contrast agents used in computer and magnetic resonance tomography.
GE Healthcare has acquired Dynamic Imaging LLC, which specialises in Web-based image and information management.
Although modern respirators present ever increasing features to enhance and simplify ventilation therapy, methods to quantify the efficacy of ventilator changes are limited.
In 2008, the European Congress of Radiology (ECR) will include a Special Focus Session titled "Women in Radiology". During an EH interview, Professor Dr Maximilian Reiser, President of ECR 2008 (Vienna, Austria) discussed this and other aspects of the new programme.
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
Germany - The Munich Municipal Hospital is network four hospital locations in Bogenhausen, Harlaching, Neuperlach and Schwabing, and facilitate the digital production and storage of X-ray images along with individual patient data and diagnosis results, using GE Healthcare's Centricity RIS/PACS.
The Acuson P10 is a new portable ultrasound device, developed and manufactured by Siemens Medical Solutions. The new system in the size of a Blackberry embodies Point of Care Testing (POCT) abilities: It weighs a little more than 700 grams and could be used for earliest possible diagnostics in an intensive care unit, ambulance or medical helicopter, providing physicians with valuable information…
Some of the medical procedures and equipment showcased and discussed at the MEDICA 2007 are sure to provide medical experts with plenty of discussion material. In cardiac diagnostic imaging a minor revolution is taking place, with ultrasound procedures increasing in significance. But innovation in x-ray methods is also continuing.
The spatial-anatomic visualisation offered by MRI already provides immense diagnostic possibilities for cardiology. However, as yet, the potential of this imaging modality is far from exploited, according to Professor Bernd Hamm (right), of the Radiology Department at the Charité Hospital, Berlin. Daniela Zimmermann of European Hospital, asked him why.
A next-generation diagnostic tool for cardiovascular disease, using a nanoscale iron particle, is now under development at a unique industry-government-university named Nano AG. A report from Siemens describes the research and progress at the centre
It has only recently been discovered that very often it is not the size of the plaque in the coronary vessels but its inflammation status that determines the occurrence of a cardiac infarction.
By Thaddeus Chodakauskas BS RDMS and Steve Feinstein MD FACC
